Search results
Order by most recent / most popular / relevance
Results: 1-10 of 114
Teva Canada Innovation v. Attorney General of Canada
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 8 2013
The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an
Definition of “innovative drug” does not include variations
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 23 2013
This is an appeal by Takeda of a decision of the Court, in which the Court upheld the decision of the Minister of Health to refuse to list Takeda’s
Intellectual property weekly abstracts bulletin
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 1 2013
The Court granted a Prohibition Order to AstraZeneca, preventing Ranbaxy from entering the market with a generic version of ompeprazole until the
Patent refused listing on the Patent Register
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 30 2012
The Federal Court dismissed a judicial review of a decision of the Minister of Health refusing to list a patent on the Patent Register
Court refuses to reconsider or vary its decision relating to redetermination
- Borden Ladner Gervais LLP
- -
- Canada
- -
- December 7 2010
The Patented Medicines Prices Review Board (PMPRB) made a decision that Teva’s product COPAXONE had been sold at an excessive price
Divisional patent application can be filed by applicant not named in original application
- Borden Ladner Gervais LLP
- -
- Canada
- -
- December 15 2010
This case is a judicial review of a decision of the Commissioner of Patents where recognition of a patent application as a divisional application was denied
Lilly v. Apotex
- Borden Ladner Gervais LLP
- -
- Canada
- -
- September 29 2010
Eli Lilly brought suit against Apotex alleging that it infringed eight (8) process patents
Appeal of decision denying interlocutory injunction dismissed
- Borden Ladner Gervais LLP
- -
- Canada
- -
- July 4 2011
This was an appeal of a decision of the Federal Court, refusing an interlocutory motion
Court grants motion to reopen trial and admit new evidence
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 27 2011
The Federal Court granted leave to reopen the trial and admit new evidence in a matter under reserve, in which no reasons or judgement have issued
Commissioner cannot undo acceptance of maintenance fees
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 18 2011
In this case, the Court made several findings of fact relating to the timing of events
Current Search
- Workarea - Patents
- Workarea - Healthcare
- Jurisdiction - Canada
- Author - Chantal Saunders